DEGANO, MASSIMO
 Distribuzione geografica
Continente #
NA - Nord America 245
EU - Europa 97
AS - Asia 49
OC - Oceania 1
Totale 392
Nazione #
US - Stati Uniti d'America 245
SE - Svezia 63
CN - Cina 32
IT - Italia 18
SG - Singapore 14
FI - Finlandia 5
DE - Germania 4
GB - Regno Unito 3
DK - Danimarca 2
KZ - Kazakistan 2
FR - Francia 1
IE - Irlanda 1
JP - Giappone 1
NZ - Nuova Zelanda 1
Totale 392
Città #
Ashburn 83
Shanghai 24
Washington 20
Boardman 19
Lawrence 19
Princeton 19
New York 17
Los Angeles 9
Milan 9
Seattle 7
Singapore 7
Helsinki 5
Rome 4
London 3
Astana 2
Auckland 1
Chicago 1
Copenhagen 1
Dianalund 1
Dublin 1
Hanover 1
Missaglia 1
Naples 1
Santa Clara 1
Tokyo 1
Verona 1
Wuhan 1
Totale 259
Nome #
ALPS-Like Phenotype Caused by ADA2 Deficiency Rescued by Allogeneic Hematopoietic Stem Cell Transplantation 22
A Novel RGD-4C-Saporin Conjugate Inhibits Tumor Growth in Mouse Models of Bladder Cancer 21
A pH-Regulated Quality Control Cycle for Surveillance of Secretory Protein Assembly 21
Progressive quality control of secretory proteins in the early secretory compartment by ERp44 20
Crystal structure of human ERp44 shows a dynamic functional modulation by its carboxy-terminal tail 17
HIGHER ORDER IMMUNOGLOBULIN REPERTOIRE RESTRICTIONS IN CLL: THE ILLUSTRATIVE CASE OF STEREOTYPED SUBSETS #2 AND #169 17
Over 30% of patients with splenic marginal zone lymphoma express the same immunoglobulin heavy variable gene: ontogenetic implications 15
Combinatorial allosteric modulation of agonist response in a self-interacting G-protein coupled receptor 15
The ERC1 scaffold protein implicated in cell motility drives the assembly of a liquid phase. 13
T-cell defects in patients with ARPC1B germline mutations account for combined immunodeficiency 12
Distinct homotypic B-cell receptor interactions shape the outcome of chronic lymphocytic leukaemia 11
Crystal structure of a hypoallergenic isoform of the major birch pollen allergen Bet v 1 and its biological function 10
Characterization of inosine-uridine nucleoside hydrolase (RihC) from Escherichia coli 10
CRYSTAL-STRUCTURES OF SOYBEAN BETA-AMYLASE REACTED WITH BETA-MALTOSE AND MALTAL - ACTIVE-SITE COMPONENTS AND THEIR APPARENT ROLES IN CATALYSTS 10
Mycobacterium tuberculosis pyrazinamide resistance determinants: a multicenter study 10
The anti-tumoral potential of the saporin-based uPAR-targeting chimera ATF-SAP 9
Crystal structure to 1.7 angstrom of the Escherichia coli pyrimidine nucleoside hydrolase YeiK, a novel candidate for cancer gene therapy 9
Disease-associated mutations in the coil 2B domain of human lamin A/C affect structural properties that mediate dimerization and intermediate filament formation 8
Crystal structure of a gamma delta T cell receptor ligand T22: A truncated MHC-like fold 8
The alpha beta T-cell receptor heterodimer: Crystal clear at last 8
Molecular Approaches to the Control of Infectious Diseases 7
Structural Basis of Cellular Immune recognition 7
Structural basis of plasticity in T cell receptor recognition of a self peptide MHC antigen 7
Cloning, purification, crystallization and X-ray analysis of the Escherichia coli pyrimidine nucleoside hydrolase YeiK 7
alpha beta T cell receptor interactions with syngeneic and allogeneic ligands: Affinity measurements and crystallization 7
A new chimeric enzyme for fluorouridine activation in cancer suicide gene therapy 7
Crystal structure of mouse CD1d bound to the self ligand phosphatidylcholine: A molecular basis for NKT cell activation 6
Accurate description of nitrogenous base flexibility in classical molecular dynamics simulations of nucleotides bound to proteins 6
A functional hot spot for antigen recognition in a superagonist TCR/MHC complex 6
New Determinants in the Catalytic Mechanism of Nucleoside Hydrolases from the Structures of Two Isozymes from Sulfolobus solfataricus 6
PRIMARY STRUCTURE AND BINDING CHARACTERISTICS OF LOCUST AND HUMAN MUSCLE FATTY-ACID-BINDING PROTEINS 6
Nucleotide insertions and deletions in chronic lymphocytic leukemia. A CLL specific deletion among IGHV3-21 expressing cases with stereotyped receptors 6
Trypanosomal nucleoside hydrolase. A novel mechanism from the structure with a transition-state inhibitor 6
The A ' and F ' pockets of human CD1b are both required for optimal presentation of lipid antigens to T cells 6
Active site plasticity revealed from the structure of the enterobacterial N-ribohydrolase RihA bound to a competitive inhibitor 5
Generation of functional HLA-DR*1101 tetramers receptive for loading with pathogen or tumour derived synthetic peptides 5
Evaluation of Nucleoside Hydrolase Inhibitors for Treatment of African Trypanosomiasis 5
Structure, Oligomerization and Activity Modulation in N-Ribohydrolases 5
Structures of catalytic cycle intermediates of the Pyrococcus furiosus methionine adenosyltransferase demonstrate negative cooperativity in the archaeal orthologues 5
New insights into the mechanism of nucleoside hydrolases from the crystal structure of the Escherichia coli YbeK protein bound to the reaction product 5
Mechanism of Action of the Tumor Vessel Targeting Agent NGR-hTNF: Role of Both NGR Peptide and hTNF in Cell Binding and Signaling 5
SYNTHESIS AND STRUCTURE OF THE 1ST PHOSPHINE OXIDE COMPLEX OF COPPER(I) - EVIDENCE FOR A MARKED BORDERLINE CHARACTER OF THE METAL CENTER 5
Crystal structure of a hypoallergenic isoform of the major birch pollen allergen Bet v 1 and its likely biological function as a plant steroid carrier 5
IGHV gene insertions and deletions in chronic lymphocytic leukemia: "CLL-biased" deletions in a subset of cases with stereotyped receptors 5
Phenotypic clustering of lamin A/C mutations in neuromuscular patients 5
Dynamic features of the selective pressure on the human immunodeficiency virus type 1 (HIV-1) gp120 CD4-binding site in a group of long term non progressor (LTNP) subjects 5
IL-27, but not IL-35, inhibits neuroinflammation through modulating GM-CSF expression 5
Structural basis for PHD(V)C5HCH(NSD1)-C2HR(Nizp1) interaction: implications for Sotos syndrome 5
An alpha beta T cell receptor structure at 2.5 angstrom and its orientation in the TCR-MHC complex 5
The N-Terminal Domain of NPHP1 Folds into a Monomeric Left-Handed Antiparallel Three-Stranded Coiled Coil with Anti-apoptotic Function 4
IGLV3-21∗01 is an inherited risk factor for CLL through the acquisition of a single-point mutation enabling autonomous BCR signaling 4
Structures of purine nucleosidase from Trypanosoma brucei bound to isozyme-specific trypanocidals and a novel metalorganic inhibitor 3
Emerging principles for T cell receptor recognition of antigen in cellular immunity 3
Molecular recognition of lipid antigens by T cell receptors 2
Probing the activation requirements for naive CD8(+) T cells with Drosophila cell transfectants as antigen presenting cells 2
Structure and Mechanism of the 6-Oxopurine Nucleosidase from Trypanosoma brucei brucei 2
Structural basis of 2C TCR allorecognition of H-2L(d) peptide complexes 2
Inosine-uridine nucleoside hydrolase from Crithidia fasciculata. Genetic characterization, crystallization, and identification of histidine 241 as a catalytic site residue 2
Type 1 Diabetes in STAT Protein Family Mutations: Regulating the Th17/Treg Equilibrium and Beyond 2
Energy Landscapes Associated with Macromolecular Conformational Changes from Endpoint Structures 1
Three-dimensional structure of the inosine-uridine nucleoside N-ribohydrolase from Crithidia fasciculata 1
Fine specificity of TCR complementarity-determining region residues and lipid antigen hydrophilic moieties in the recognition of a CD1-lipid complex 1
Role of Disputed Mutations in the rpoB Gene in Interpretation of Automated Liquid MGIT Culture Results for Rifampin Susceptibility Testing of Mycobacterium tuberculosis 1
Structural requirements for antigen presentation by mouse CD1 1
Structural basis for substrate specificity in group I nucleoside hydrolases 1
N-Glycosylation of the Ig Receptors Shapes the Antigen Reactivity in Chronic Lymphocytic Leukemia Subset #201 1
Totale 464
Categoria #
all - tutte 8.000
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.000


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203 1 0 0 2 0 0 0 0 0 0 0 0
2020/20213 0 0 0 0 0 3 0 0 0 0 0 0
2021/202213 0 0 0 2 0 1 0 2 3 0 3 2
2022/2023160 42 24 12 1 1 16 1 9 3 46 0 5
2023/2024265 1 7 36 24 52 58 2 28 0 9 13 35
2024/20257 7 0 0 0 0 0 0 0 0 0 0 0
Totale 464